In 2015, The Lancet published findings from the PURE study — the Prospective Urban Rural Epidemiology study — which followed 139,691 adults across 17 countries on five continents for a median of four years. The researchers measured grip strength using a handheld dynamometer. They measured blood pressure. They measured a range of cardiovascular risk markers. And then they tracked who died, and from what.
Every 5 kilogram drop in grip strength was associated with 16% higher all-cause mortality. The same relationship held for cardiovascular death, non-cardiovascular death, heart attack, and stroke. When grip strength and systolic blood pressure were placed in the same predictive model, grip strength was the stronger predictor of all-cause and cardiovascular mortality. Blood pressure is the most universally measured clinical risk factor on earth. A hand squeeze outperformed it.
This is not a niche finding. It has been replicated across populations, age groups, and decades of follow-up in multiple independent datasets. The relationship between muscular strength and survival is one of the most consistent signals in the epidemiological literature on longevity. And it is measured in almost no clinical setting, ever, despite the fact that the test costs roughly £30 and takes 30 seconds.
Almost every adult who walks into a clinic gets a blood pressure measurement. Almost none get their grip strength measured. Your blood pressure cuff misses this. A dynamometer doesn’t. Strength is a vital sign. We just haven’t agreed to treat it as one yet.
Why Muscle Is the System, Not the Symptom
Grip strength is a proxy for something much larger than the forearm muscles doing the squeezing. It correlates tightly with quadriceps strength, with total lean mass, and with neuromuscular function — the integrated capacity of the nervous system to recruit and coordinate muscle fibres. When that proxy deteriorates, it’s reflecting systemic muscular decline rather than localised weakness.
The mechanism behind why this tracks with mortality so reliably is not mysterious. Skeletal muscle is the body’s largest insulin-sensitive tissue, its largest reservoir of amino acids, and — crucially — an endocrine organ in its own right. During contraction, muscle secretes a family of signalling proteins called myokines: IL-6 (which in this context is anti-inflammatory, unlike the chronic IL-6 of metabolic disease), irisin, BDNF precursors, FGF21. These signals regulate fat metabolism, improve insulin sensitivity, support neurological health, and modulate inflammation.
When skeletal muscle mass declines — the condition called sarcopenia — the entire metabolic system loses its primary shock absorber. Insulin sensitivity falls. Blood glucose rises. Inflammatory tone increases. The liver compensates by producing more glucose. The pancreas compensates by producing more insulin. The HOMA-IR climbs. This is not a consequence of ageing that is separate from metabolic disease. It is a driver of it. Muscle loss and metabolic deterioration are the same process viewed from different angles.
Sarcopenia — the progressive loss of muscle mass and function with age — is not an inevitable consequence of getting older. It is the consequence of insufficient stimulus on a system that atrophies in the absence of load. The stimulus is the point.
Six Tests. Under Ten Minutes. No Laboratory Required.
The following tests have all been validated as independent predictors of longevity, functional decline, or mortality risk in peer-reviewed literature. None of them are in a standard clinical assessment. All of them can be done at home or in a gym in under two minutes each. The purpose is not to generate anxiety about your numbers — it’s to give you a baseline, a direction, and a reason to act on it.
What These Tests Are Actually Measuring
The reason all six of these tests predict mortality is that they’re different windows onto the same underlying biological reality — the reserve capacity of the muscular, cardiovascular, and neurological systems. Not their current performance, but their reserve: how much capacity above the minimum functional threshold remains. That reserve is what gets drawn on during illness, surgery, acute stress, and the accumulated demands of ageing.
The TDG Connection — What Blood Chemistry Adds
These functional tests tell you the functional consequence of the underlying biology. Blood chemistry tells you the upstream cause. The combination is where the clinical picture becomes actionable.
Low grip strength with elevated HOMA-IR and high fasting insulin points toward insulin resistance as the metabolic driver of muscle quality deterioration — the muscle is metabolically impaired, not just undertrained. Low grip with low ferritin and low vitamin D points toward nutritional inadequacy limiting muscle protein synthesis. Low grip with elevated hsCRP and low testosterone (on blood chemistry) points toward inflammatory sarcopenia — the specific pattern where chronic low-grade inflammation accelerates muscle catabolism.
The intervention for each of these is different. Without the blood chemistry, you know you need to get stronger. With the blood chemistry, you know why you’re not, and you address the upstream cause rather than just adding exercise to a system that is metabolically too compromised to respond to it adequately. This is the test, don’t guess principle applied to longevity rather than to illness — the same logic, the same methodology, the same value of having data before building a protocol.
Grip strength: Three squeezes each hand, record best. Note the number and date it.
Sit-to-stand from floor: Score out of 10. Below 7 is a flag. Below 5 is an urgent flag.
Single-leg balance, eyes closed: Can you hold 10 seconds each leg? If not, this is the first intervention priority — balance responds quickly to training.
30-second chair stand: Count your reps. Compare to the age-referenced norms.
Resting heart rate: First thing tomorrow morning, lying down. Record it. Check it again in 3 months after any training intervention.
These numbers mean nothing in isolation. They mean a great deal as a baseline you can track over years. The direction of travel is the clinical signal.
The PURE study researchers noted that grip strength is cheap, easy to measure, and available anywhere in the world — making it a particularly valuable marker for global health surveillance. What they described as an advantage for population-level epidemiology is equally true at the individual level. The dynamometer that tells you your grip strength is declining over years is telling you something real about your biology, and it’s telling you before the blood tests flag, before the symptoms arrive, and while you can still do something meaningful about it.
Strength is a vital sign. It’s just one that medicine hasn’t fully integrated into practice yet. You can integrate it yourself, starting with the tests above, starting today.